share_log

Roth Capital Reinstates Buy on Apexigen, Announces $15 Price Target

Roth Capital Reinstates Buy on Apexigen, Announces $15 Price Target

羅斯資本恢復對阿比斯根的買入,宣佈 15 美元目標價
Benzinga Real-time News ·  2023/01/24 08:32

Roth Capital analyst Kumaraguru Raja reinstates Apexigen (NASDAQ:APGN) with a Buy and announces $15 price target.

羅斯資本分析師庫瑪拉古拉賈以買入恢復阿比肯(NASDAQ:APGN),並宣布 15 美元的目標價格。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論